Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析

◆英語タイトル:Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014775
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月12日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:金融サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Unipol Gruppo Finanziario S.p.A. – Strategy, SWOT and Corporate Finance Report
Summary

Unipol Gruppo Finanziario S.p.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Unipol Gruppo Finanziario S.p.A (UGF) is an insurance and banking service provider. UGF offers a wide range of banking products and services such as current accounts, savings accounts, certificate of deposits, credit cards, commercial loans, pension plans and mortgages. It also provides insurance products such as life insurance, motor insurance, accident insurance, health insurance, fire or damage insurance, marine insurance, aviation insurance, goods in transit insurance, and general third party insurance. In addition, it provides asset leasing services, asset management services, financial planning services, retail banking services and investment banking solutions. The group’s operations are spanned across Italy. UGF is headquartered in Bologna, Italy.

The group reported gross premiums earned of EUR14,187.8 million during fiscal year 2016 (FY2016), representing a decrease of 9.5%. Its net premiums was EUR113,786.8 million in FY2016, representing a decrease of 9.7% over FY2015.

Scope

- Detailed information on Unipol Gruppo Finanziario S.p.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Unipol Gruppo Finanziario S.p.A. in the form of a SWOT analysis
- An in-depth view of the business model of Unipol Gruppo Finanziario S.p.A. including a breakdown and examination of key business segments
- Intelligence on Unipol Gruppo Finanziario S.p.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Unipol Gruppo Finanziario S.p.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Unipol Gruppo Finanziario S.p.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Unipol Gruppo Finanziario S.p.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Unipol Gruppo Finanziario S.p.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Unipol Gruppo Finanziario S.p.A.: Company Overview
Unipol Gruppo Finanziario S.p.A.: Overview and Key Facts
Unipol Gruppo Finanziario S.p.A.: Overview
Unipol Gruppo Finanziario S.p.A.: Key Facts
Unipol Gruppo Finanziario S.p.A.: Key Employees
Unipol Gruppo Finanziario S.p.A.: Key Employee Biographies
Unipol Gruppo Finanziario S.p.A.: Major Products and Services
Unipol Gruppo Finanziario S.p.A.: Company History
Unipol Gruppo Finanziario S.p.A.: Management Statement
Unipol Gruppo Finanziario S.p.A.: Locations and Subsidiaries
Unipol Gruppo Finanziario S.p.A.: Key Competitors
Unipol Gruppo Finanziario S.p.A.: Company Analysis
Unipol Gruppo Finanziario S.p.A.: Business Description
Unipol Gruppo Finanziario S.p.A.: SWOT Analysis
Unipol Gruppo Finanziario S.p.A.: SWOT Overview
Unipol Gruppo Finanziario S.p.A.: Strengths
Unipol Gruppo Finanziario S.p.A.: Weaknesses
Unipol Gruppo Finanziario S.p.A.: Opportunities
Unipol Gruppo Finanziario S.p.A.: Threats
Unipol Gruppo Finanziario S.p.A.: Corporate Financial Deals Activity
Unipol Gruppo Finanziario S.p.A.: Financial Deals Overview
Unipol Gruppo Finanziario S.p.A.: Top Deals 2013 – 2017YTD*
Unipol Gruppo Finanziario S.p.A.: Advisors
Unipol Gruppo Finanziario S.p.A.: Top Financial Advisors
Unipol Gruppo Finanziario S.p.A.: Divestments
Unipol Gruppo Finanziario S.p.A.: Recent Developments
Unipol Gruppo Finanziario S.p.A.: News and Events Summary
Unipol Gruppo Finanziario S.p.A.: Contracts
Unipol Gruppo Finanziario S.p.A.: Financial Deals
Unipol Gruppo Finanziario S.p.A.: Financial Performance
Unipol Gruppo Finanziario S.p.A.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Unipol Gruppo Finanziario S.p.A.: Key Facts
Table 2: Unipol Gruppo Finanziario S.p.A.: Key Employees
Table 3: Unipol Gruppo Finanziario S.p.A.: Locations and Subsidiaries
Table 4: Unipol Gruppo Finanziario S.p.A.: Key Competitors
Table 5: Unipol Gruppo Finanziario S.p.A.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Unipol Gruppo Finanziario S.p.A.: Top Deals 2013 - 2017YTD*
Table 7: Unipol Gruppo Finanziario S.p.A.: Financial Advisor Ranking by Value (US$m)
Table 8: Unipol Gruppo Finanziario S.p.A.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 9: Unipol Gruppo Finanziario S.p.A.: Divestments by Geography (2013 - YTD*2017)
Table 10: Unipol Gruppo Finanziario S.p.A.: News and Events Summary
Table 11: Unipol Gruppo Finanziario S.p.A.: Contracts
Table 12: Unipol Gruppo Finanziario S.p.A.: Financial Deals
Table 13: Unipol Gruppo Finanziario S.p.A.: Financial Performance
Table 14: Unipol Gruppo Finanziario S.p.A.: Strategy and Operations

★海外企業調査レポート[Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • China Yangtze Power Co Ltd (600900):企業の財務・戦略的SWOT分析
    Summary China Yangtze Power Co Ltd (CYPC) is a renewable energy company that offers power distribution and sale services. The company's services offerings include power distribution covering various areas including consultancy, energy procurement, distribution network construction, energy permit tra …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • EMC Insurance Group Inc.:企業の戦略・SWOT・財務情報
    EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report Summary EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Air Lease Corporation:企業の戦略・SWOT・財務情報
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • ET Solar Group Corporation-エネルギー分野:企業M&A・提携分析
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a wide variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and …
  • Quantum Genomics SA (ALQGC):企業の財務・戦略的SWOT分析
    Summary Quantum Genomics SA (Quantum Genomics) is a biopharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (B …
  • Vattenfall:企業の戦略・SWOT・財務情報
    Vattenfall - Strategy, SWOT and Corporate Finance Report Summary Vattenfall - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • EBS Technologies GmbH:医療機器:M&Aディール及び事業提携情報
    Summary EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務分析
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AnaMar AB-医療機器分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Guodian United Power Technology Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guodian United Power Technology Co Ltd (United Power), a subsidiary of China Guodian Corp, is a wind turbine equipment manufacturing company that concentrates on green energy industry. The company provides wind turbine generator systems. It provides product portfolio such as wind turbine ser …
  • Swift Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Corona Remedies Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Corona Remedies Pvt Ltd (Corona) is a drugs manufacturing company that develops, manufactures, and markets pharmaceutical products. The company’s products include antiallergic drugs, antibiotic drugs, analgesic drugs, antimalarial drugs, heamatonics, hormonal drugs, nutritional supplements, …
  • EDF Renewable Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • Alliance Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • Costain Group Plc (COST):企業の財務・戦略的SWOT分析
    Costain Group Plc (COST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆